369 related articles for article (PubMed ID: 23994140)
41. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
42. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
43. Mycophenolic acid attenuates the tumour necrosis factor-α-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways.
Olejarz W; Bryk D; Zapolska-Downar D; Małecki M; Stachurska A; Sitkiewicz D
Eur J Clin Invest; 2014 Jan; 44(1):54-64. PubMed ID: 24134657
[TBL] [Abstract][Full Text] [Related]
44. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
Reinhard C; Shamoon B; Shyamala V; Williams LT
EMBO J; 1997 Mar; 16(5):1080-92. PubMed ID: 9118946
[TBL] [Abstract][Full Text] [Related]
45. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
46. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract][Full Text] [Related]
47. Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.
He CL; Yi PF; Fan QJ; Shen HQ; Jiang XL; Qin QQ; Song Z; Zhang C; Wu SC; Wei XB; Li YL; Fu BD
Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):215-24. PubMed ID: 23171279
[TBL] [Abstract][Full Text] [Related]
48. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
49. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
[TBL] [Abstract][Full Text] [Related]
50. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
51. Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
Valentim-Silva JR; Macedo SRA; de Barros NB; Dos Santos Ferreira A; da Silva JHM; de Figueiredo Nicolete LD; Nicolete R
Int Immunopharmacol; 2020 Aug; 85():106640. PubMed ID: 32470884
[TBL] [Abstract][Full Text] [Related]
52. Differential radio-adaptive responses in BALB/c and C57BL/6 mice: pivotal role of calcium and nitric oxide signalling.
Premkumar K; Nair J; Shankar BS
Int J Radiat Biol; 2019 Jun; 95(6):655-666. PubMed ID: 30676176
[No Abstract] [Full Text] [Related]
53. IRAK and TAK1 are required for IL-18-mediated signaling.
Wald D; Commane M; Stark GR; Li X
Eur J Immunol; 2001 Dec; 31(12):3747-54. PubMed ID: 11745395
[TBL] [Abstract][Full Text] [Related]
54. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y
BioData Min; 2020; 13():17. PubMed ID: 33082858
[TBL] [Abstract][Full Text] [Related]
55. Transcriptional regulation of tenascin genes.
Chiovaro F; Chiquet-Ehrismann R; Chiquet M
Cell Adh Migr; 2015; 9(1-2):34-47. PubMed ID: 25793574
[TBL] [Abstract][Full Text] [Related]
56. Zinc ions as effectors of environmental oxidative lung injury.
Wu W; Bromberg PA; Samet JM
Free Radic Biol Med; 2013 Dec; 65():57-69. PubMed ID: 23747928
[TBL] [Abstract][Full Text] [Related]
57. Mitochondria in innate immune signaling.
Banoth B; Cassel SL
Transl Res; 2018 Dec; 202():52-68. PubMed ID: 30165038
[TBL] [Abstract][Full Text] [Related]
58. Stress and radiation-induced activation of multiple intracellular signaling pathways.
Dent P; Yacoub A; Contessa J; Caron R; Amorino G; Valerie K; Hagan MP; Grant S; Schmidt-Ullrich R
Radiat Res; 2003 Mar; 159(3):283-300. PubMed ID: 12600231
[TBL] [Abstract][Full Text] [Related]
59. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.
Frobøse H; Rønn SG; Heding PE; Mendoza H; Cohen P; Mandrup-Poulsen T; Billestrup N
Mol Endocrinol; 2006 Jul; 20(7):1587-96. PubMed ID: 16543409
[TBL] [Abstract][Full Text] [Related]
60. Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review.
Najafi M; Ahmadi A; Mortezaee K
Cell Biol Int; 2019 Nov; 43(11):1206-1222. PubMed ID: 31136035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
